Group 1 - Tian Da Pharmaceutical (00455.HK) closed at HKD 0.136 on April 10, down 12.26% from the previous trading day, with an intraday low of HKD 0.135, marking a new low in nearly a year [1] - The capital flow on that day showed a main inflow of HKD 0.000 million and an outflow of HKD 0.297 million, resulting in a net outflow of HKD 0.30 million [1] Group 2 - Tian Da Pharmaceutical focuses on developing traditional Chinese medicine (TCM) and aims to become a competitive player in drug research, medical technology, and health management [2] - The company is building a comprehensive TCM industry chain, establishing quality control standards for Chinese medicinal materials, and creating a new type of TCM clinic called "Tian Da Clinic" [2] - Tian Da Pharmaceutical leverages internet technology, big data, and artificial intelligence to integrate online and offline TCM services, providing convenient health services [2] - The product range includes traditional Chinese medicine, chemical drugs, biological products, health products, and medical devices, covering various therapeutic areas [2] - The company is expanding its market presence both domestically in China and internationally, with marketing centers in Shenzhen and Zhuhai, and subsidiaries in Hong Kong and Australia [2] - Tian Da Pharmaceutical aims to meet the growing healthcare demands by collaborating with quality partners and integrating advanced treatment technologies [2]
天大药业盘中最低价触及0.135港元，创近一年新低